The Escherichia coli paa operon encodes enzymes of the phenylacetic acidutilization pathway that metabolizes phenylacetate in the form of a coenzyme A (CoA) derivative. The phenylacetyl-coenzyme A oxygenase complex, which has been postulated to contain five components designated PaaABCDE, catalyzes ring hydroxylation of phenylacetyl-CoA. The PaaAC subcomplex shows low sequence similarity to other bacterial multicomponent monooxygenases (BMMs) and forms a separate branch on the phylogenetic tree. PaaAC, which catalyzes the hydroxylation reaction, was purified and crystallized in the absence of a bound ligand as well as in complexes with CoA, 3-hydroxybutyryl-CoA, benzoyl-CoA and the true substrate phenylacetyl-CoA. Crystals of the ligandfree enzyme belonged to space group P2 1 2 1 2 1 and diffracted to 2.65 Å resolution, whereas complexes with CoA and its derivatives crystallized in space group P4 1 2 1 2 and diffracted to $2.0 Å resolution. PaaAC represents the first crystallized BMM hydroxylase that utilizes a CoA-linked substrate.
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Introduction
Escherichia coli is capable of aerobically metabolizing aromatic compounds (Díaz et al., 2001) . In particular, this bacterium contains a pathway for the degradation of phenylacetic acid (PA), which is metabolized into intermediates for the TCA cycle. The degradation of PA proceeds through a CoA derivative, which is an unusual route for the aerobic catabolism of aromatic compounds (Ferrá ndez et al., 1998) . In some bacteria this pathway serves as the core of a complex metabolic network (catabolon) that is capable of the degradation of 2-phenylethylamine, styrene, phenylacetaldehyde, phenylacetyl amides, n-phenylalkanoic acids with an even number of C atoms and phenylacetyl esters (Luengo et al., 2001) . The range of chemistries performed by this catabolon shows promise for biotechnological applications such as the enzymatic synthesis of penicillins, whole-cell processes of styrene biodegradation, the production of new bioplastics and the production of 2-hydroxyphenylacetate (Luengo et al., 2001) . E. coli utilizes only a subset of the catabolon routes related to the utilization of PA and 2-phenylethylamine (Díaz et al., 2001) .
The genes coding for PA-metabolizing enzymes are organized into three transcription units within the paa gene cluster: paaZ, paaABCDEFGHIJK and paaXY (Ferrá ndez et al., 1998) . The first two transcription units encode enzymes utilized in this pathway. The third unit encodes a negative regulator of paa genes, PaaX, while the role of PaaY is unknown. The proposed route for PA metabolism is presented in Fig. 1 (Ismail et al., 2003) . The first step in the pathway is the activation of PA by phenylacetate-CoA ligase (PaaK), yielding phenylacetyl-CoA (PA-CoA). The aromatic ring of the latter is subsequently aerobically hydroxylated by the putative phenylacetylCoA oxygenase complex (PaaABCDE), followed by ring opening by PaaJ, PaaZ and PaaG to yield -hydroxyadipyl-CoA. This compound is oxidized by PaaF and PaaH to -ketoadipyl-CoA, which is cleaved to the convenient metabolites succinyl-CoA and acetyl-CoA by -ketoadipyl-CoA thiolase (PaaJ) (Nogales et al., 2007) .
The phenylacetyl-coenzyme A oxygenase complex PaaABCDE has been classified within the bacterial multicomponent monooxygenases (BMMs; Ferná ndez et al., 2006) . BMMs are divided into six major groups (Notomista et al., 2003; Ferná ndez et al., 2006) and include soluble methane monooxygenase (MMO; Rosenzweig et al., 1993 Rosenzweig et al., , 1997 , phenol hydroxylase (Cafaro et al., 2004; Sazinsky et al., 2006) , toluene/o-xylene monooxygenase (ToMO; McCormick et al., 2006; Notomista et al., 2009 ) and toluene 4-monooxygenase (T4MO; Moe et al., 2006; Bailey et al., 2008) . Phylogenetic analysis has shown that phenylacetyl-CoA oxygenase is the prototype of a new class within the large BMM family (Ferná ndez et al., 2006) .
By analogy with other monooxygenases, PaaA, PaaC and PaaD have been predicted to form the dimeric hydroxylase (ACD) 2 core of the complex (Ferná ndez et al., 2006) . Based on sequence homology, the PaaA subunit was proposed to contain a di-iron centre coordinated by four negatively charged residues and two histidines and to perform the oxygenase reaction, PaaC, which shows a low level of sequence identity to PaaA but is devoid of the catalytic centre, was proposed to play a structural role in complex formation, PaaD was thought to be the small subunit of the hydroxylase, PaaE has been assigned the role of the reductase component of the complex, which delivers electrons from NADH or NADPH through FAD or FMN and an iron-sulfur cluster to the iron in the active centre of PaaA, and PaaB has been proposed to play a regulatory role in the complex (Ferná ndez et al., 2006) .
We have expressed PaaA and PaaC, the main components of the hydroxylase. We showed that PaaA expressed alone is insoluble, but that it can be obtained in a soluble form when co-expressed with PaaC, with which it forms a stable complex. We have obtained well diffracting crystals of the PaaAC complex with bound ligands, including CoA, 3-hydroxybutyryl-CoA, benzoyl-CoA and phenylacetyl-CoA, which represents the true substrate. We have also crystallized the ligand-free form of PaaAC.
Materials and methods

Cloning, expression and purification
The paaA and paaC genes were PCR-amplified from E. coli K-12 genomic DNA and cloned into a modified pET15b vector (Novagen) designated pFO4, a pRDSFDuet-1 vector (Novagen) derivative designated pZL72 and a pCDFDuet-1 vector derivative designated pZL71 (Novagen). In all cases E. coli BL21 (DE3) was used for protein expression.
An overnight inoculum of the transformed E. coli expression strain was diluted 200-fold into fresh TB medium supplemented with appropriate antibiotics and cells were allowed to grow at 310 K until the absorbance at 600 nm reached 0.6. Protein expression was induced by adding 0.1 mM isopropyl -d-1-thiogalactopyranoside (IPTG) and the culture was grown overnight at 293 K. Cells were harvested by centrifugation and disrupted by sonication and the soluble protein fraction was obtained after centrifugation at 20 000g for 30 min at 277 K.
We selected PaaA co-expressed with His 6 -PaaC for further purification. The cells were lysed in a buffer containing 50 mM HEPES pH 7.5, 0.4 M NaCl, 5%(v/v) glycerol, 20 mM imidazole, 0.5 mM benzamidine, 10 mM leupeptin. The protein supernatant was loaded onto an Ni-NTA column pre-equilibrated with lysis buffer, incubated Proposed steps of the aerobic metabolic pathway of phenylacetate in E. coli (Ismail et al., 2003) .
for 2 h at room temperature and washed with lysis buffer supplemented with 40 mM imidazole. Protein was eluted with a buffer consisting of 50 mM HEPES pH 7.5, 50 mM NaCl, 5%(v/v) glycerol, 250 mM imidazole (Fig. 2) . Immediately after elution, the protein buffer was exchanged into buffer consisting of 50 mM HEPES pH 7.5, 50 mM NaCl, 5 mM DTT using a PD-10 desalting column (GE Healthcare) and the protein sample was loaded onto a preequilibrated Superose 12 (GE Healthcare) column for size-exclusion chromatography. To remove excess PaaC, the leading fractions (3 and 4; Fig. 3 ) from the peak corresponding to the PaaAC complex were pooled together and re-chromatographed on the same column.
Crystallization
The purified PaaA-His 6 -PaaC complex (PaaAC) was concentrated to 8 mg ml À1 using an Ultracel-30k centrifugal filter and mixed with 5 mM d,l-3-hydroxybutyryl-CoA. Crystallization screening was performed by sitting-drop vapour diffusion at 293 K by mixing 0.4 ml PaaAC solution with 0.3 ml reservoir solution using a Hydra Plus One crystallization robot (Matrix Technologies, Hudson, New Hampshire, USA). Two crystallization conditions, A5 and H10, were identified from initial screening with the Protein Complex suite (Qiagen). Optimized crystals were grown using hanging-drop vapour diffusion in 24-well Linbro plates using equal volumes (1 ml) of protein and one of two different reservoir solutions: (i) 0.1 M PIPES pH 6.5, 15%(v/v) PEG 550 MME or (ii) 0.1 M PIPES pH 6.5, 5%(v/v) 2-propanol, 5%(v/v) PEG 550 MME. phenylacetyl-CoA was used to obtain the complexes of PaaAC with these ligands under the same crystallization conditions as described above.
Crystallization conditions for free PaaAC (no substrate bound) were found while attempting to optimize the protein buffer using an in-house extended pH/buffer screen (Jancarik et al., 2004) . Crystals of PaaAC were obtained by hanging-drop vapour diffusion from 100 mM ADA pH 5.5. The cryosolvent for these crystals consisted of 100 mM ADA pH 5.5, 25%(v/v) MPD. These crystals were 50 mm in size in all three dimensions.
X-ray data collection
X-ray diffraction data were collected on the CMCF1 beamline at the Canadian Light Source using a MAR 300 CCD detector. Data integration and scaling was performed with HKL-2000 (Otwinowski & Minor, 1997) . The diffraction limits, crystal space groups and unitcell parameters of the obtained crystals are presented in Table 1 .
Results and discussion
PaaA-PaaC complex formation
PaaA and PaaC cloned into a derivative of pET15b vector could be expressed independently in E. coli in high yield, but only PaaC was soluble. Since the hydroxylase components of BMMs are composed of at least (catalytic) and (structural) subunits (Notomista et al., 2003) , we cloned PaaA into the second molecular cloning site in pRDSFDuet-1 vector (no tag) and co-expressed this protein with N-terminally His-tagged PaaC. Both proteins were expressed in high yield and were soluble.
Purification and characterization of PaaAC
The co-expressed PaaA and His 6 -PaaC were initially loaded onto an Ni-NTA agarose column and both were retained after a thorough wash, indicating the formation of a stable PaaAC complex which could be eluted from the column (Fig. 2) . Size-exclusion chromatography on a Superose 12 column showed two partially overlapping peaks with apparent molecular masses of $180 and $55 kDa. SDS-PAGE showed that the first eluting peak contained the PaaAC complex, while the second peak contained only His 6 -PaaC, suggesting that PaaC was expressed in a higher yield exceeding the stoichiometric ratio. To improve the homogeneity of the solution, the leading fractions from the peak containing the PaaAC complex were rerun on a Superose 12 column (Fig. 2) and the central fraction of the protein peak showed a unimodal distribution with an apparent molecular weight of $160 kDa as analyzed by dynamic light scattering. Since the calculated molecular weight of the PaaAC complex is $65 kDa, there appears to be a heterotetramer or heterohexamer in solution.
Crystallization of native PaaAC and its complexes with substrate and substrate analogues
Initial crystals of PaaAC were obtained complexed with d,l-3-hydoxybutyryl-CoA. Crystals appeared within 2-3 d (Fig. 4) . SDS-PAGE analysis of redissolved crystals proved that both PaaA and PaaC subunits were present in the crystal (data not shown). Crystals of PaaAC complexed with coenzyme A, benzoyl-CoA and the substrate phenylacetyl-CoA were obtained under similar conditions and were all isomorphous. These crystals diffracted to resolutions in the range 2.03-2.25 Å and a full set of diffraction data was collected on the CMCF1 beamline at the Canadian Light Source (Table 1) .
Attempts to cocrystallize the PaaAC complex with its substrate and a metal ion were undertaken with iron (ferrous ammonium sulfate), cobalt (CoCl 2 ) and manganese (MnCl 2 ). Crystals did not grow at iron molar concentrations higher than the concentration of PaaA or at a cobalt concentration higher than 0.25 of that of PaaA. However, crystals could be grown with 5 mM manganese. An X-ray fluorescence scan of these crystals showed no evidence that metals were present in the crystals. We therefore performed soaking experiments of PaaAC crystals in solution containing iron. This resulted in no apparent absorption of the iron by the protein at low iron concentrations or led to a significant loss of resolution when higher iron concentrations were used. We collected diffraction data to 5.8 Å resolution from one such crystal soaked with 10 mM ferrous ammonium sulfate. This experiment suggests a rather low affinity of PaaA for iron and that some rearrangement of the protein is induced by iron binding.
Continued crystallization screening of ligand-free PaaAC finally resulted in the identification of suitable conditions that were different from those that supported crystal growth of PaaAC complexed with CoA derivatives. These crystals appeared from solution containing only buffer at pH 5.5 with no other precipitating agent (Table 1) .
Patterson self-rotation analysis of the P4 1 2 1 2 crystal form corresponding to ligand-bound protein only indicated the presence of peaks corresponding to crystallographic symmetry. No other peaks that could indicate the presence of NCS in the asymmetric unit were found. A self-rotation function for the P2 1 2 1 2 crystal (ligand-free protein) indicated peaks that correspond to P422 crystal symmetry. Indeed, the a and b cell dimensions are very close to the ac diagonal in the tetragonal space group. However, this data set could not be merged with good statistics in the tetragonal space group, indicating the presence of only pseudo-tetragonal symmetry. No other significant peaks were found.
Determination of all structures is in progress.
The data collection described in this paper was performed at the Canadian Light Source, which is supported by NSERC, NRC, CIHR and the University of Saskatchewan. This work was supported by Tetragonal form PaaAC crystals. The shapes of the free PaaAC crystals and of those cocrystallized with substrate or analogues were similar. This figure shows crystals of free PaaAC.
